GlobeNewswire
ARS Pharmaceuticals Announces Conference Call and Webcast for its Fourth Quarter and Full Year 2025 Financial Results and Participation at Upcoming Conferences
➖
AI Sentiment
Neutral
5/10
Latest updates and market news for SPRY
AI Sentiment
Neutral
5/10
Share this news page